CompletedNCT03895307Updated Apr 13, 2021Results posted

Comparison of Kinesio Taping and Local Injection in Chronic Low Back Pain

An interventional study of kinesio tape and local anesthetic in Chronic Low Back Pain, sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. Completed at 2 sites in Turkey. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2021-04-13.

Sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · Not applicable, Interventional, and Treatment

Phase: Not applicable
Study type: Interventional
Enrollment: 84
Allocation: Randomized
Ages: 18 Years to 75 Years
Sex: All

Study summary

Low back pain can be seen in every period of life. More than 80 percent of the society complain of low back pain at any time of life. Although the frequency of applying to a health institution due to low back pain varies from one society to the other, it takes place in the first three places in each community. Low back pain should be differentiated as new (acute) and long-term (chronic). In the treatment of chronic low back pain, rest, education, pharmacological treatment, physical therapy, painful point injections, surgical interventions, kinesio taping can be applied. The most frequently used physical therapy modalities for treatment of chronic low back pain are superficial and deep heat modalities (hot pack, infrared, ultrasound, microwave diathermy radar) and analgesic effective electrotherapy (TENS, interferential flows) modalities. One of the most important treatments is exercise therapy. In cases where conventional treatment of chronic low back pain is insufficient, that is, the patient's pain is still ongoing and functional recovery is insufficient, some alternative methods are also applied. These treatments include ozone, prolotherapy injection applications, dry needling, acupuncture, phytotherapy, balneotherapy, kinesio taping and so on. The aim of this study is to compare the efficacy of painful point injection and kinesio taping treatments in lumbar region in patients with chronic low back pain.

Read the detailed description

Approximately 84 volunteer patients will be included in the study, patients older than 18 years, under 75 years of age, with a minimum of 3 months of mechanical back pain, Visual Analog Scale score of at least 60 patients will be included. Who are older than 18 years of age, having mental problems, having peripheral problems affecting the central nervous system, having received physical therapy to the lumbar region in the last 3 months, having been applied to the lumbar region within the last 3 months, having a history of lumbar region surgery, having a history of patients with motor deficit in the extremity, needle phobia, lidocaine and / or kinesio tape allergy, patients with wound, infection, burn, allergic lesions in the application area will not be included.

Patients included in the study will be included in the first (first), second (second), third (third) or fourth (fourth) treatment group by random number generator method.

The first group will be given the hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16. days.

The second group will be given a hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16 days.

The third group hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16. days, kinesio tape will be applied to the determined areas.

the fourth group hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16. days sham tape application will be made in the regions determined. ****

Patients in all groups will continue to use the hotpack and exercises until the 3rd month after the first day of their study. First session exercises with the same physiotherapist (stretching for back-waist, iliopsoas and hamstring muscles; exercise range of hip and waist; hip and waist isometric exercises). Each patient will do the exercises 20 minutes after the hot package application.
- saline and local anesthetic injection points to be applied to the lumbar region:
  1. Future points on spinous projections from L1 to L5
  2. Lumbar region 2 from the middle point of the spinous output bilateral and 2 cm to 4 cm lateral points
  3. To each point of the iliac lobe of iliac crest will be injected subcutaneously with 0.5 ml 0.5% lidocaine-containing local anesthetic.
  4. 6 mm 30 gauge needle tip will be used for injection.
  5. For each patient who underwent subcutaneous local anesthetic, an average of 18-20 ml of 0.5% lidocaine-containing local anesthetic and 18-20 ml of 0.09% NaCl-containing isotonic saline will be used for each patient.
  6. These points are the points of quadle technique applied in neural therapy.
    - Kinesio taping will use 2 cut-to-length I-bands with a length of about 15 cm long for one patient. Space correction technique will be used for patients. The lumbar region of the patients will be glued vertically to the paravertebral muscles vertically 3-4 cm lateral to the spinous projections. As a starting point for patients, S1 will be adhered to the vertebra without tension, then the patient will be asked to come with maximum lumbar flexion posterior.
      - For a patient in the treatment of sham kinesio taping, 2 pieces of approximately 15 cm long ends will be used to cut the curved I bands. The lumbar region of the patients will be glued vertically to the paravertebral muscles vertically 3-4 cm lateral to the spinous projections. Patients in the upright posture, kinesio tape S1 applied from the vertebra without stretching will be glued upwards and taped upwards.

Conditions studied

Chronic Low Back Pain

Browse trials for

Keywords

chronic low back pain
kinesio taping
injection
local anesthetic

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's enrollment of 84 is above the median of 60 across 1,941 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey is the lead sponsor of 104 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years to 75 Years
Sexes eligible: All
Accepts healthy volunteers: No

Inclusion criteria

Under 18 years of age under 75 years
Chronic mechanic (decreased with resting and resting) for at least 3 months
Visual Analogue Scale score of at least 60-

Exclusion criteria

Exclusion Criteria:

Having mental problems
Having the disease affecting the peripheral and central nervous system
Have received physical therapy in the lumbar region within the last 3 months
Injection into the lumbar region within the last 3 months
Having a history of waist region surgery
Low motor dysfunction in lower extremity in physical examination
Needle phobia
Is allergic to lidocaine
Kinesio tape allergy
Wound, infection, burn, allergic lesions in the application area

Study design

Phase: Not applicable
Primary purpose: Treatment
Allocation: Randomized
Intervention model: Parallel assignment
Masking: Double (Participant, Outcomes assessor)
Enrollment: 84 participants (actual)

Study arms

Experimental
kinesio taping
two 15 cm I type kinesio tape applied longitudinally
Other: kinesio tape
Placebo comparator
sham kinesio taping
two 15 cm I type kinesio tape applied longitudinally but without stretching
Other: kinesio tape
Experimental
local anesthetic
18-20 cc %0.5 lidocaine subcutaneous injection
Other: local anesthetic
Placebo comparator
local serum physiologic
18-20 cc % 0.09 NaCl subcutaneous injection
Other: local serum physiologic

Interventions

Otherkinesio tape
two 15 cm I type kinesio tape applied longitudinally
Otherlocal anesthetic
local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection
Otherlocal serum physiologic
serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection

What researchers measure

Primary outcomes

Pain Severity: Visual Analog Scale
visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain
Time frame: day 0 (before intervention)
Pain Severity: Visual Analog Scale
visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain
Time frame: day 16 (after 6th application)
Pain Severity: Visual Analog Scale
visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain
Time frame: 1 month after intervention
Pain Severity: Visual Analog Scale
visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain
Time frame: 3 months after intervention

Secondary outcomes

Disability Severity: Oswestry Disabiliy Index
Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability
Time frame: day 0 (before intervention)
Disability Severity: Oswestry Disability Index
Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability
Time frame: day 16 (after 6th application)
Disability Severity: Oswestry Disability Index
Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability
Time frame: 1 month after intervention
Disability Severity: Oswestry Disability Index
Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability
Time frame: 3 months after intervention
Patient Reported Quality of Life: Short Form 36 Physical Functioning
short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life
Time frame: day 0 (before intervention)
Patient Reported Quality of Life: Short Form 36 Physical Functioning
short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life
Time frame: day 16 (after 6th application)
Patient Reported Quality of Life: Short Form 36 Physical Functioning
short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life
Time frame: 1 month after intervention
Patient Reported Quality of Life: Short Form 36 Physical Functioning
short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life
Time frame: 3 months after intervention
Spinal Mobility: Schober Test
Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.
Time frame: day 0 (before intervention)
Spinal Mobility: Schober Test
Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.
Time frame: day 16 (after 6th application)
Spinal Mobility: Schober Test
Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.
Time frame: 1 month after intervention
Spinal Mobility: Schober Test
Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.
Time frame: 3 months after intervention
Patient Reported Quality of Life: Short Form-36 Mental Health
Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.
Time frame: day 0 before intervention
Patient Reported Quality of Life: Short Form-36 Mental Health
Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.
Time frame: day 16 (after 6th application)
Patient Reported Quality of Life: Short Form-36 Mental Health
Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.
Time frame: 1 month after intervention
Patient Reported Quality of Life: Short Form-36 Mental Health
Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.
Time frame: 3 months after intervention

Results

Posted Jul 2, 2020

Participant flow

Participant flow — Overall Study
Milestone	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Started	21	20	22	21
Completed	19	20	20	21
Not completed	2	0	2	0

Outcome measures

PrimaryPain Severity: Visual Analog Scale

visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain

Time frame:: day 0 (before intervention)
Reported as:: Mean · score on a scale

Pain Severity: Visual Analog Scale
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Pain Severity: Visual Analog Scale	7.26 ± 0.8	7.75 ± 0.44	7.8 ± 0.89	7.62 ± 0.92

PrimaryPain Severity: Visual Analog Scale

visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain

Time frame:: day 16 (after 6th application)
Reported as:: Mean · score on a scale

Pain Severity: Visual Analog Scale
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Pain Severity: Visual Analog Scale	2.89 ± 2.1	3.35 ± 2.11	2.85 ± 1.98	3.52 ± 2.13

PrimaryPain Severity: Visual Analog Scale

visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain

Time frame:: 1 month after intervention
Reported as:: Mean · score on a scale

Pain Severity: Visual Analog Scale
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Pain Severity: Visual Analog Scale	3.58 ± 2.56	4.65 ± 2.99	3.65 ± 2.36	5.81 ± 2.18

PrimaryPain Severity: Visual Analog Scale

visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain

Time frame:: 3 months after intervention
Reported as:: Mean · score on a scale

Pain Severity: Visual Analog Scale
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Pain Severity: Visual Analog Scale	4.42 ± 2.41	5.20 ± 2.94	5 ± 2.77	6.48 ± 2.22

SecondaryDisability Severity: Oswestry Disabiliy Index

Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability

Time frame:: day 0 (before intervention)
Reported as:: Mean · score on a scale

Disability Severity: Oswestry Disabiliy Index
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Disability Severity: Oswestry Disabiliy Index	17.42 ± 2.65	18.30 ± 3.45	17.1 ± 2.38	17.57 ± 1.72

SecondaryDisability Severity: Oswestry Disability Index

Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability

Time frame:: day 16 (after 6th application)
Reported as:: Mean · score on a scale

Disability Severity: Oswestry Disability Index
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Disability Severity: Oswestry Disability Index	7.68 ± 6.67	6.50 ± 6.66	6.15 ± 4.95	10.43 ± 5.07

SecondaryDisability Severity: Oswestry Disability Index

Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability

Time frame:: 1 month after intervention
Reported as:: Mean · score on a scale

Disability Severity: Oswestry Disability Index
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Disability Severity: Oswestry Disability Index	10.84 ± 8.21	10.50 ± 7.58	8.85 ± 6.67	14.38 ± 4.57

SecondaryDisability Severity: Oswestry Disability Index

Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability

Time frame:: 3 months after intervention
Reported as:: Mean · score on a scale

Disability Severity: Oswestry Disability Index
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Disability Severity: Oswestry Disability Index	13.84 ± 6.44	14.20 ± 6.52	13.35 ± 4.35	16.10 ± 3.89

SecondaryPatient Reported Quality of Life: Short Form 36 Physical Functioning

short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life

Time frame:: day 0 (before intervention)
Reported as:: Mean · score on a scale

Patient Reported Quality of Life: Short Form 36 Physical Functioning
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Patient Reported Quality of Life: Short Form 36 Physical Functioning	53.1 ± 13.08	50.75 ± 14.53	45.9 ± 12.54	50.71 ± 12.97

SecondaryPatient Reported Quality of Life: Short Form 36 Physical Functioning

Time frame:: day 16 (after 6th application)
Reported as:: Mean · score on a scale

Patient Reported Quality of Life: Short Form 36 Physical Functioning
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Patient Reported Quality of Life: Short Form 36 Physical Functioning	77.63 ± 14.75	74 ± 13.53	75 ± 15.39	74.05 ± 15.46

SecondaryPatient Reported Quality of Life: Short Form 36 Physical Functioning

Time frame:: 1 month after intervention
Reported as:: Mean · score on a scale

Patient Reported Quality of Life: Short Form 36 Physical Functioning
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Patient Reported Quality of Life: Short Form 36 Physical Functioning	68.11 ± 16.69	61.70 ± 19.47	67.20 ± 16.26	57.86 ± 16.32

SecondaryPatient Reported Quality of Life: Short Form 36 Physical Functioning

Time frame:: 3 months after intervention
Reported as:: Mean · score on a scale

Patient Reported Quality of Life: Short Form 36 Physical Functioning
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Patient Reported Quality of Life: Short Form 36 Physical Functioning	58.84 ± 13.26	55.15 ± 15.35	56.65 ± 16.27	54.05 ± 14.63

SecondarySpinal Mobility: Schober Test

Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.

Time frame:: day 0 (before intervention)
Reported as:: Mean · centimeters

Spinal Mobility: Schober Test
centimeters	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Spinal Mobility: Schober Test	4.09 ± 0.58	4.37 ± 0.77	3.75 ± 0.88	4.38 ± 0.72

SecondarySpinal Mobility: Schober Test

Time frame:: day 16 (after 6th application)
Reported as:: Mean · centimeters

Spinal Mobility: Schober Test
centimeters	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Spinal Mobility: Schober Test	4.36 ± 0.43	4.37 ± 0.77	4.27 ± 0.63	4.59 ± 0.49

SecondarySpinal Mobility: Schober Test

Time frame:: 1 month after intervention
Reported as:: Mean · centimeters

Spinal Mobility: Schober Test
centimeters	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Spinal Mobility: Schober Test	4.36 ± 0.43	4.42 ± 0.74	4.27 ± 0.63	4.54 ± 0.54

SecondarySpinal Mobility: Schober Test

Time frame:: 3 months after intervention
Reported as:: Mean · centimeters

Spinal Mobility: Schober Test
centimeters	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Spinal Mobility: Schober Test	4.36 ± 0.43	4.42 ± 0.74	4.2 ± 0.61	4.54 ± 0.54

SecondaryPatient Reported Quality of Life: Short Form-36 Mental Health

Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.

Time frame:: day 0 before intervention
Reported as:: Mean · score on a scale

Patient Reported Quality of Life: Short Form-36 Mental Health
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Patient Reported Quality of Life: Short Form-36 Mental Health	68 ± 0	67.5 ± 2.23	68 ± 0	68 ± 0

SecondaryPatient Reported Quality of Life: Short Form-36 Mental Health

Time frame:: day 16 (after 6th application)
Reported as:: Mean · score on a scale

Patient Reported Quality of Life: Short Form-36 Mental Health
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Patient Reported Quality of Life: Short Form-36 Mental Health	79.79 ± 7.48	78.6 ± 5.51	78 ± 5.51	77.52 ± 2.18

SecondaryPatient Reported Quality of Life: Short Form-36 Mental Health

Time frame:: 1 month after intervention
Reported as:: Mean · score on a scale

Patient Reported Quality of Life: Short Form-36 Mental Health
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Patient Reported Quality of Life: Short Form-36 Mental Health	77.16 ± 9.29	73.10 ± 7.96	76.6 ± 7.05	71.81 ± 4.97

SecondaryPatient Reported Quality of Life: Short Form-36 Mental Health

Time frame:: 3 months after intervention
Reported as:: Mean · score on a scale

Patient Reported Quality of Life: Short Form-36 Mental Health
score on a scale	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic
Patient Reported Quality of Life: Short Form-36 Mental Health	74.42 ± 7.96	72.1 ± 7.90	73.60 ± 7.93	71.33 ± 4.83

Adverse events

Collected over adverse events were not monitored/assessed. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
Group	Deaths	Serious	Other
Kinesio Tape	—	—	—
Sham Kinesio Taping	—	—	—
Local Anesthetic	—	—	—
Local Serum Physiologic	—	—	—

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic	Total
<=18 years	0	0	0	0	0
Between 18 and 65 years	20	17	17	20	74
>=65 years	1	3	5	1	10

Age, Continuous
Age, Continuous(years)	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic	Total
Mean	39.67 ± 15.72	47.20 ± 16.60	47.82 ± 15.95	41.48 ± 15.69	44.05 ± 16.09

Sex: Female, Male
Sex: Female, Male(Participants)	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic	Total
Female	9	8	5	12	34
Male	12	12	17	9	50

Race (NIH/OMB)
Race (NIH/OMB)(Participants)	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic	Total
American Indian or Alaska Native	0	0	0	0	0
Asian	0	0	0	0	0
Native Hawaiian or Other Pacific Islander	0	0	0	0	0
Black or African American	0	0	0	0	0
White	21	20	22	21	84
More than one race	0	0	0	0	0
Unknown or Not Reported	0	0	0	0	0

Region of Enrollment
Region of Enrollment(participants)	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic	Total
Turkey	21	20	22	21	84

Body Mass Index
Body Mass Index(kg/m2)	Kinesio Taping	Sham Kinesio Taping	Local Anesthetic	Local Serum Physiologic	Total
Mean	27.63 ± 4.70	27.25 ± 3.88	27.05 ± 4.47	27.05 ± 3.73	27.24 ± 4.13

Study locations

2 sites

Sultan 2.Abdülhamid Han Training and Research Hospital
Istanbul, Eyalet/Yerleşke 34000, Turkey
Sultan Abdülhamid Han Training and Research Hospital
Istanbul, Eyalet/Yerleşke 34000, Turkey

References and documents

Study documents

Protocol and statistical analysis plan · Aug 1, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — other researchers would get information from the main researcher. therefore it was not shared.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Apr 13, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT03895307
Lead sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Responsible party: Sponsor
First posted: Mar 29, 2019
Start date: Apr 1, 2019
Primary completion: Jun 1, 2019
Completion: Aug 1, 2019
Results posted: Jul 2, 2020
Last update: Apr 13, 2021

Study contacts

ADEM ERBİROL

study director · sultan abdulhamid han

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Back Pain→

Other studies from this sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Start the discussion

Comparison of Kinesio Taping and Local Injection in Chronic Low Back Pain

Study summary

Conditions studied

Browse trials for

Keywords

In context

Back Pain

Lead sponsor

Who can participate

✓Inclusion criteria

✕Exclusion criteria

Study design

Study arms

Interventions

What researchers measure

Primary outcomes

Secondary outcomes

Results

Participant flow

Outcome measures

Adverse events

Baseline characteristics

Study locations

References and documents

Study documents

Individual participant data

Updates

Registry details

Key details

Study contacts

Oversight

Not currently enrolling

Follow this study

Discussion

Other studies in this condition

Other studies from this sponsor

Inclusion criteria

Exclusion criteria